The presence of CD8+ and CD4+ T cell responses specific to these antigens was analyzed by stimulation of PBMCs from 36 NSCLC patients with corresponding mixture of antigenic peptides. The gene discussed is CD4; the disease is non-small cell lung carcinoma.